Eight induced pluripotent stem cell lines (iPSCs) derived from two patients with Leukocyte adhesion deficiency Type I (LAD I) with mutations in the ITGB2 gene

Leukocyte Adhesion Deficiency Type I (LAD I) is a rare inborn error of immunity caused by mutations in the ITGB2 gene coding for β2-integrin CD18 on the surface of leukocytes. Affected patients display severe clinical manifestations with life threatening infections and inflammatory complications due to an impaired ability of leukocytes to transmigrate from the blood vessel to the tissue. Here we describe the generation of eight induced pluripotent stem cell lines from two patients with LAD I and mutations in the ITGB2 gene. With this project we contribute patient individualized cell lines for explorative research in a rare disease.

Authors

Institutions

Publication Details

Journal
Stem Cell Research
Published
2024-10-25
DOI
https://doi.org/10.1016/j.scr.2024.103598
Primary Topic
Pluripotent Stem Cells Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Eight induced pluripotent stem cell lines (iPSCs) derived from two patients with Leukocyte adhesion deficiency Type I (LAD I) with mutations in the ITGB2 gene

Ute Modlich, Manfred Hoenig, Hermann Kreyenberg, Melanie Bremm et al.
Stem Cell Research
Pluripotent Stem Cells Research
article

Eight induced pluripotent stem cell lines (iPSCs) derived from two patients with Leukocyte adhesion deficiency Type I (LAD I) with mutations in the ITGB2 gene

Ute Modlich, Manfred Hoenig, Hermann Kreyenberg, Melanie Bremm, Sabine Huenecke, Peter Bader, Eva‐Maria Jacobsen, Shahrzad Bakhtiar, Franziska Schenk, Renate König, Stefan Zahn, Marcel G. E. Rommel, Klaus Schwarz, Nina V. Fuchs, Zyrafete Kuçi, Julia Fekadu-Siebald
article en

Abstract

Leukocyte Adhesion Deficiency Type I (LAD I) is a rare inborn error of immunity caused by mutations in the ITGB2 gene coding for β2-integrin CD18 on the surface of leukocytes. Affected patients display severe clinical manifestations with life threatening infections and inflammatory complications due to an impaired ability of leukocytes to transmigrate from the blood vessel to the tissue. Here we describe the generation of eight induced pluripotent stem cell lines from two patients with LAD I and mutations in the ITGB2 gene. With this project we contribute patient individualized cell lines for explorative research in a rare disease.

Stem Cell ResearchVol. 81
Goethe University Frankfurt (DE), University of California, Santa Cruz (US), German Red Cross (DE), Swiss Institute for Regenerative Medicine (CH), Paul Ehrlich Institut (DE)
Goethe-Universität Frankfurt am Main
Zero hunger
Openalex Percentile: Top 83%
Pluripotent Stem Cells Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.